UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EGF mutant receptor vIII as a molecular target in cancer therapy

Endocrine-related cancer, 2001-06, Vol.8 (2), p.83-96

2001

Volltextzugriff (PDF)

Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII

Cancer research (Chicago, Ill.), 1997-09, Vol.57 (18), p.4130-4140

1997

Volltextzugriff (PDF)

Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results

Journal of clinical oncology, 1998-06, Vol.16 (6), p.2202-2212

1998

Volltextzugriff (PDF)

Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas

Cancer research (Chicago, Ill.), 1995-07, Vol.55 (14), p.3140-3148

1995

Volltextzugriff (PDF)

Glioma-associated Antigen Expression in Oligodendroglial Neoplasms: Tenascin and Epidermal Growth Factor Receptor

The journal of histochemistry and cytochemistry, 2000-08, Vol.48 (8), p.1103-1110

2000

Volltextzugriff (PDF)

Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors

Clinical cancer research, 1995-08, Vol.1 (8), p.859-864

1995

Volltextzugriff (PDF)

Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate

Cancer research (Chicago, Ill.), 1997-04, Vol.57 (8), p.1510-1515

1997

Volltextzugriff (PDF)

Tumor antigens in astrocytic gliomas

Glia, 1995-11, Vol.15 (3), p.244-256

1995

Volltextzugriff (PDF)

Prognostic Applications of the Epidermal Growth Factor Receptor and Its Ligand, Transforming Growth Factor-α

JNCI : Journal of the National Cancer Institute, 1998-06, Vol.90 (11), p.799-813

1998

Volltextzugriff (PDF)

Phase I Trial Results of Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 Treatment of Patients With Newly Diagnosed Malignant Gliomas

Journal of clinical oncology, 2000-11, Vol.18 (22), p.3862-3872

2000

Volltextzugriff (PDF)

Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro

Glycoconjugate journal, 2000-10, Vol.17 (10), p.717-726

2000

Volltextzugriff (PDF)

Identifying potential tumor markers and antigens by database mining and rapid expression screening

Genome research, 2000-09, Vol.10 (9), p.1393-1402

2000

Volltextzugriff (PDF)

Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc

The American journal of pathology, 1988-03, Vol.130 (3), p.472-484

1988

Volltextzugriff (PDF)

Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts

Laboratory investigation, 1991-06, Vol.64 (6), p.833

1991

Volltextzugriff (PDF)

Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII)

Biochemical journal, 1997-06, Vol.324 ( Pt 3) (3), p.855-861

1997

Volltextzugriff (PDF)

Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII‐specific scFv

International journal of cancer, 2000-12, Vol.88 (6), p.962-969

2000

Volltextzugriff (PDF)

Establishment and Characterization of the Human Medulloblastoma Cell Line and Transplantable Xenograft D283 Med

Journal of neuropathology and experimental neurology, 1985-11, Vol.44 (6), p.592-605

1985

Volltextzugriff (PDF)

Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies : use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts

Cancer research (Chicago, Ill.), 1995-10, Vol.55 (19), p.4375-4382

1995

Volltextzugriff (PDF)

Immunobiology of malignant astrocytomas: Malignant astrocytomas

Seminars in oncology, 1994-04, Vol.21 (2), p.149-161

1994

Volltextzugriff (PDF)

Tenascin expression in human glioma cell lines and normal tissues

Journal of neuroimmunology, 1992, Vol.36 (1), p.41-55

1992

Volltextzugriff (PDF)

Left ventricular wall stress and systolic function in untreated primary hypertension

Hypertension (Dallas, Tex. 1979), 1985, Vol.7 (1), p.97-104

1985

Volltextzugriff (PDF)

Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin

Journal of neuroimmunology, 1994-07, Vol.52 (2), p.127-137

1994

Volltextzugriff (PDF)

Heterogeneity of Genotypic and Phenotypic Characteristics of Fifteen Permanent Cell Lines Derived from Human Gliomas

Journal of neuropathology and experimental neurology, 1981-05, Vol.40 (3), p.201-229

1981

Volltextzugriff (PDF)

EGFRvIII as a promising target for antibody-based brain tumor therapy

Brain tumor pathology, 2000-06, Vol.17 (2), p.71-78

2000

Volltextzugriff (PDF)

Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas

Acta neuropathologica, 1991-01, Vol.82 (1), p.45-54

1991

Volltextzugriff (PDF)

1 – 25 von 195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(172)

Publikationsform

Artikel
(192)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(134)
Science & Technology
(114)
Life Sciences & Biomedicine
(112)
Biological And Medical Sciences
(82)
Medical Sciences
(72)
Animals
(63)
Female
(63)
Male
(62)
Middle Aged
(52)
Mice
(48)
Aged
(38)
Oncology
(32)
Cell Line
(29)
Adult
(27)
Neurology
(26)
Cardiovascular System & Cardiology
(25)
Mice, Nude
(24)
Glioma - Immunology
(23)
Tumors Of The Nervous System. Phacomatoses
(23)
Neurosciences & Neurology
(22)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

EGF mutant receptor vIII as a molecular target in cancer therapy

Cell surface localization and density of the tumor-associated variant of the epidermal growth factor receptor, EGFRvIII

Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results

Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas

Glioma-associated Antigen Expression in Oligodendroglial Neoplasms: Tenascin and Epidermal Growth Factor Receptor

Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors

Improved targeting of an anti-epidermal growth factor receptor variant III monoclonal antibody in tumor xenografts after labeling using N-succinimidyl 5-iodo-3-pyridinecarboxylate

Tumor antigens in astrocytic gliomas

Prognostic Applications of the Epidermal Growth Factor Receptor and Its Ligand, Transforming Growth Factor-α

Phase I Trial Results of Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 Treatment of Patients With Newly Diagnosed Malignant Gliomas

Monoclonal anti-GD3 antibodies selectively inhibit the proliferation of human malignant glioma cells in vitro

Identifying potential tumor markers and antigens by database mining and rapid expression screening

Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-myc

Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts

Receptor dimerization is not a factor in the signalling activity of a transforming variant epidermal growth factor receptor (EGFRvIII)

Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII‐specific scFv

Establishment and Characterization of the Human Medulloblastoma Cell Line and Transplantable Xenograft D283 Med

Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies : use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts

Immunobiology of malignant astrocytomas: Malignant astrocytomas

Tenascin expression in human glioma cell lines and normal tissues

Left ventricular wall stress and systolic function in untreated primary hypertension

Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin

Heterogeneity of Genotypic and Phenotypic Characteristics of Fifteen Permanent Cell Lines Derived from Human Gliomas

EGFRvIII as a promising target for antibody-based brain tumor therapy

Disialoganglioside GD2 in human neuroectodermal tumor cell lines and gliomas

Suchergebnisse filtern